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iceberg: a report of two cases with literature
review
El Bachir Benjelloun1*, Said Aitalalim1, Leila Chbani2, Ihsan Mellouki3, Khalid Mazaz1 and Kahlid Aittaleb1Abstract
Colonic adenocarcinoma revealed by metastatic anorectal fistula is rare, with few cases in the literature. Such
lesions can be taken for the more common manifestation of a benign perianal abscess or fistula. Once diagnosed,
the management of such conditions remains controversial. We herein report two cases with perianal fistula that
were subsequently found to have developed perianal adenocarcinoma on biopsy. Further colonic investigation
revealed a rectosigmoid adenocarcinoma. Histology and immunohistochemical staining was identical in both
primary and metastatic tumors. Preoperative chemoradiation with further rectal low anterior resection and local
excision of metastatic anal fistula was performed. There is no recurrence after 3 years of follow-up.
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Distal implantation by a proximal adenocarcinoma into
an anal fistula remains a rare condition. It has been pre-
viously reported that exfoliated colorectal cancer cells
can implant in distal locations such as the staple lines
[1] and hemorrhoidectomy wounds [2] resulting in
tumor recurrence. The same pathological mechanism
can be expected in a case of colorectal adenocarcinoma
seeding into anal fistula. Cancer implantation is usually
suspected when carcinoma originating in an anal fistula
has a similarity of histological findings between the pri-
mary colorectal cancer and the metastatic lesion [3].
Furthermore, the fistula must be present with a syn-
chronous colorectal cancer. The diagnosis of such condi-
tions remains difficult mainly when the primary tumor is
unknown and the chronic anal fistula seems to be be-
nign. More challenging is the management of such peri-
neal tumors, as the literature is divided between
surgeons who prefer radical abdominoperineal resection
(APR) [4-17] and others who opt for sphincter-sparing
surgery [18-26].* Correspondence: benjelloun19@hotmail.com
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distribution, and reproduction in any mediumWe herein present two cases of patients diagnosed
with rectosigmoid adenocarcinoma revealed by meta-
static perineal fistula, and treated with neoadjuvant
chemotherapy followed by low anterior resection and
local excision of the perineal tumor.Case 1
A 55-year-old man presented with a 10-year history of
recurrent anal fistula. He had no history of inflammatory
bowel disease. Physical examination revealed several ex-
ternal openings, in the right and left perianal regions.
The internal opening was located posteriorly in proctos-
copy. The patient underwent fistulectomy with seton
placement in fistula tracts. The pathology of the fistula
excision did not show any malignancy. After 3 months
of follow-up, a discharging nodule appeared in the fistula
tract wound. Rectal examination did not reveal any ab-
normalities in the anal canal or the rectum. The nodule
was biopsied, and adenocarcinoma was found on histo-
logy review. Further colonic investigation revealed a rec-
tosigmoid tumor.
Histology of both the primary tumor and the perianal
nodule revealed a well-differentiated adenocarcinoma
with cytokeratin 20 (CK20)+ and cytokeratin 7 (CK7)-tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 MRI of the pelvis showing the perineal mass (black arrow) and rectosigmoid tumor (white arrow).
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(Figure 1) and endoanal ultrasound (Figure 2) showed a
perianal mass with anal sphincter involvement. Computer
tomography (CT) did not show any distant metastasis.Figure 2 Endoanal ultrasound showing the perineal mass with sphincThe two modalities of the treatment (including APR or
neoadjuvant chemoradiation followed by low rectal resec-
tion and local excision of perineal mass with the risk of re-
currence and incontinence) were discussed with theter involvement (black arrow).
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weeks after a course of chemoradiation (45 Gy + 5
Fluorouracil), the patient underwent rectal anterior re-
section with colorectal anastomosis and local excision
of the perianal mass which responded very well to the
neoadjuvant therapy. Histopathological analysis of the
excised nodule and rectosigmoid tumor revealed a well-
differentiated adenocarcinoma as a primary tumor
without lymph node involvement (T3N0M0), while the
perianal mass showed a complete response following
chemoradiotherapy. There is no recurrence after 3 years
follow-up.Case 2
A 68-year-old man presented to the emergency room
with a perianal abscess. He had no history of anal fistula.
Examination under anesthesia was performed confirming
the perianal abscess with an internal opening in the anal
dentate line, proving the origin was a cryptoglandular fis-
tula. Simple drainage was performed. Because the cavity
of the abscess had an atypically indurated border, biopsy
was done. Histology revealed a well-differentiated adeno-
carcinoma. Further investigation, including rectosigmoi-
doscopy, MRI of the pelvis and a CT scan, showed a large
carcinoma 26 cm from the anal verge and a perianal mass
extending to the anal sphincter, which was confirmed by
endoanal ultrasound.Figure 3 Histology of the perineal fistula. a) Glandular proliferation (circle
with necrosis. c) Immunohistochemical staining immunoreactivity with antNo distant metastasis was noticed. Histology of the
primary tumor was the same as the perianal mass.
Immunohistochemistry for CK7 and CK20 was per-
formed on tissues to distinguish colorectal adenocarci-
noma from anal gland carcinoma. Both the colorectal
cancer and the perianal tumor were CK7- and CK20+
(Figure 3). The modalities of the treatment (including
APR or neoadjuvant chemoradiation followed by low
rectal resection and local excision of the perineal mass
with the risk of recurrence and incontinence) were dis-
cussed with the patient and informed consent was
obtained. Preoperative chemoradiation (45 Gy + 5 Fluo-
rouracil), was administered. Follow-up MRI 6 weeks
after chemoradiation showed dramatic shrinkage of the
perineal tumor. Surgery consisted of rectal anterior re-
section with colorectal anastomosis and local excision of
the perianal mass. Pathological results of the rectosig-
moid tumor revealed well-differentiated adenocarcinoma
without lymph node involvement (T2N0M0). The perianal
mass was completely sterilized. After 3 years follow-up
there is no recurrence.
Discussion
Cancer of the colon and rectum can be spread by direct
extension, transperitoneal, lymphatic, and hematogenous
spread. Spreading by implantation has been also described
[2]. In 1907, Ryall reported that many solid cancers were
implanted in the operative field, and described the) surmounted by a squamous epithelium (arrow). b) Adenocarcinoma
i-CK20.
Table 1 Reported cases of implantation metastasis from colorectal adenocarcinoma into a fistula in ano






Operation Follow up without
recurrrence
Guiss A [4] 1954 47 M S 2 m Dukes
A
Mod APR 1 y 2 m
Killingback et al.
[5]
1965 63 M S 8 y Dukes
A
Well APR NA
Parnes [6] 1976 47 M S 3 m Dukes
B
Well APR 18 m
Rollinson and
Dundas [7]
1984 65 M Rs 20 y NA Well APR 10 m
Ueta et al. [8] 1991 66 F S 44 Dukes
B
Well APR 6 m
Thomas and
Thompson [9]





1998 75 M UR 40 y Dukes
B
Well APR 1 y
Isbister [18] 2000 47 M Rs 2 y M Dukes
C
Mod 1- LR NA
2- LOR
Isbister [18] 2000 39 M S N 1 y M NA NA Refused APR NA
Tokuhara et al.
[11]
2001 69 M S 5 y Dukes
B
Mod APR 1 y
Yoshimura et al.
[12]
2001 59 M Rs 29 y Dukes
C
Mod APR 3 y 7 m
Shinohara et al.
[19]
2001 36 M MR 16 y Dukes
C
Mod AR + LR 6 m
Kouraklis et al.
[13]





2002 50 M S NA Dukes
C
Well TPE 3 y 8 m
Shimoyama et al.
[15]
2003 61 M Rs 5 y Dukes
C
Mod APR 5 y
Hyman and Kida
[16]







2004 72 M S 4 y NA NA S + LR + adj CH
RTH
1 y 2 m
Gupta et al. [21] 2005 44 M Left colon 1 m Dukes
C
Mod LH= LR 3 y
Hamada et al.
[23]




AR + LR 1 y
Ishiyama et al.
[24]
2006 53 M UR 20 y Dukes
C




2006 72 M Rs 2 y Dukes
B
Mod S + LR + adj Ch R 14 m
Gravante et al.
[17]














After 2 years 2- LR
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Table 1 Reported cases of implantation metastasis from colorectal adenocarcinoma into a fistula in ano (Continued)








S, sigmoid; Rs, rectosigmoid; R, rectum; Mod, moderately differentiated; Well, well-differentiated; APR, abdominoperineal resection; TPE, total pelvic exenteration;
LAR, low anterior resection; LOR, local resection; adj, adjuvant; Neoadju chemoradia, neoadjuvant chemoradiation therpay; y, year(s); m, months; M, male; F, female;
A, alive; L, left colon; LH, left hemicolectomy; UR, Upper rectum; MR, middle rectum; ADK, adenocarcinoma.CH: chemotherapy; RTH; radiotherapy; NA: not available.
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the first case of cancer implantation into an anal fistula in
1954. Since then, a few other cases have been reported in
the literature and the concept of cancer implantation has
become widely accepted. We found 23 articles describing
24 patients with metastatic anal fistula arising from colorec-
tal carcinoma [4-26]. Details of the cases are summarized in
Table 1, along with the current patients. The diagnosis of
such conditions remains difficult, mainly when the pri-
mary tumor is undiagnosed and the chronic anal fistula
seems to be benign. It is, therefore the change in behavior
of the anal fistula, such as the appearance of a nodule or
perianal abscess with indurated borders as is described in
our patients that should raise the red flag and awareness
of possible malignancy, making biopsy and further colonic
investigation mandatory. Histological differentiation and
immunohistochemical staining must show the same
characteristic in both tumors. More specifically, immu-
nohistochemistry of CK7 and CK20 remains the exam-
ination of choice to distinguish between colonic tumor
tissues and tumors originating from the anal glands
[16]. Ramalingam et al. have previously described that anal
glands were strongly immunoreactive to antibodies against
CK7 but not to CK20 [28]. In our case, tumor cells of both
lesions were positive for CK20 and negative for CK7 anti-
bodies. We considered the tumor of the anal fistula as me-
tastasis of the rectosigmoid cancer in both cases.
Controversies remain in the management of metastatic
anal fistula. It is difficult to define the best treatment
from the literature, as some authors have performed
APR, while others have chosen local resection.
After discussing the modality of treatment (either APR
or neoadjuvant chemoradiation following by anterior
rectal resection and local excision emphasizing the risk
and the benefit of each approach, in particular risk of re-
currence and incontinence) with our patients, we opted
for preoperative chemoradiation (45 Gy), followed by an-
terior resection of the rectum and local excision of
perianal metastasis after 6 weeks. Our choice was guided
by the age of patients, differentiation and immunohisto-
chemical characteristics of the primary and metastatic
tumors, evidence of sphincter involvement on MRI and
endoanal ultrasound and the absence of distant metasta-
sis on abdominal CT. Furthermore, perineal masses in
both cases shrank dramatically after chemoradiation.
Consistent with that, the pathology report showed acomplete response to chemoradiotherapy in both cases.
The primary tumors were without lymph node metasta-
ses. Chemoradiation has been indicated as an adjuvant
therapy in some previous reports [17,20,25], but not as a
neoadjuvant treatment. The benefit of neoadjuvant ver-
sus adjuvant chemoradiation is still unclear. Based on a
literature review of colorectal cancers implanting in a
fistula track, patients undergoing local resection versus
APR showed similar outcomes in terms of local recur-
rence. Nevertheless, it is difficult to make any concrete
conclusion about the best approach, as the length of
follow-up of reported cases is short.
Conclusion
It is strongly recommended to be aware of any unusual
changes in the clinical features of the fistula in ano either
before or after surgery (such as increased discharge,
bloody discharge, nodule formation, uncommonly slow
healing or scar indurations) and not to hesitate to perform
biopsy in order to exclude any malignancies that may be
the visible part of the iceberg. Sphincter-saving surgery is
an option that should be discussed with the patient.
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